Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 1 Diabetes: What We Know So Far and Future Trials. // Endocrinology & Metabolism Clinics of North America. – URL: https://www.sciencedirect.com/science/article/pii/S0889852926000241?dgcid=rss_sd_all
Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 1 Diabetes: What We Know So Far and Future Trials. Endocrinology & Metabolism Clinics of North America. https://www.sciencedirect.com/science/article/pii/S0889852926000241?dgcid=rss_sd_all
“Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 1 Diabetes: What We Know So Far and Future Trials.” Endocrinology & Metabolism Clinics of North America.
@article{article44626,
title = {Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 1 Diabetes: What We Know So Far and Future Trials},
journal = {Endocrinology \& Metabolism Clinics of North America},
url = {https://www.sciencedirect.com/science/article/pii/S0889852926000241?dgcid=rss_sd_all}
}